All news from Marine Medicine

New Therapy Might Improve Leukemia

A Wilmot Cancer Institute study uncovers how a single gene could be at fault in myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could improve AML survival rates, which have not budged in recent years.